FAMU Professor Patents Drug; Will Limit Infections Stemming From HIV/AIDS, Cancer Treatment
Florida A&M University Professor Seth Ablordeppey has received a US patent for his development of the drug Cryptolepine. His changes to the drug are projected to make for stronger response to infections commonly brought by HIV/AIDS and chemotherapy treatment, and will cause fewer side effects for patients.
“This research has been in the works for more than a decade and I am grateful to FAMU for providing the environment and opportunity for this discovery,” said Ablordeppey. “With the discovery of these new agents we hope to deal one more blow to the opportunistic infections that continue to wreak havoc in our communities.”
It is Dr. Ablordeppey’s second patent while serving as a FAMU faculty member. Two years ago, he patented a psychosis treatment method for mammals.